Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.22 USD | +9.11% | +16.71% | +17.01% |
Jul. 08 | Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug | MT |
Jul. 01 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.01% | 198M | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- BTIG Downgrades Outlook Therapeutics to Neutral From Buy